Viewing Study NCT04764227


Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2026-02-24 @ 5:03 PM
Study NCT ID: NCT04764227
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-08-03
First Post: 2021-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module